Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Genpact Ltd shares valued at $3,274,487 were sold by Mehta Piyush on Sep 12 ’25. At $42.58 per share, Mehta Piyush sold 76,902 shares. The insider’s holdings dropped to 134,880 shares worth approximately $5.63 million following the completion of this transaction.
Also, Kalra Balkrishan sold 55,000 shares, netting a total of over 2,384,850 in proceeds. Following the sale of shares at $43.36 each, the insider now holds 295,246 shares.
Before that, PIYUSH MEHTA had added 76,902 shares to its account. In a trade valued at $3,274,240, the Officer bought Genpact Ltd shares for $42.58 each.
Analysts at TD Cowen upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in early February. As of January 21, 2025, Jefferies has increased its “Hold” rating to a “Buy” for G. Earlier on July 17, 2024, JP Morgan upgraded its rating. Their new recommendation was “a Neutral” for G stock which previously was a “an Underweight”.
Analyzing G Stock Performance
On last trading session, Genpact Ltd [NYSE: G] rose 1.06% to $41.77. The stock’s lowest price that day was $41.24, but it reached a high of $41.96 in the same session. During the last five days, there has been a drop of approximately -2.86%. Over the course of the year, Genpact Ltd shares have jumped approximately 6.31%.
Is Genpact Ltd subject to short interest?
Stocks of Genpact Ltd saw a sharp rise in short interest on 2025-08-29 jumping by 23533.0 shares to 6.95 million. Data from Yahoo Finance shows that the short interest on 2025-07-31 was 6.93 million shares. A jump of 0.34% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 3.44 of the overall float, the days-to-cover ratio (short ratio) jumped to 3.44.
Which companies own the most shares of Genpact Ltd (G)?
In terms of Genpact Ltd share price expectations, FactSet research, analysts set an average price target of 53 in the next 12 months, up nearly 28.24% from the previous closing price of $41.33. Analysts anticipate Genpact Ltd stock to reach 53 by 2025, with the lowest price target being 53. In spite of this, 6 analysts ranked Genpact Ltd stock as Hold at the end of 2025. On January 30, 2024, Mizuho assigned a price target of “a Neutral” to the stock and initiated coverage with a $40.
